Mesenchymal Stem Cells Transplantation in newly diagnosed type-1 diabetes patients:a phase I/II Randomized Controlled trial

Background & Aim Background null Insulin injection is a routine treatment for type-1 diabetes which couldn't result in physiologic reaction to blood glucose changes and patients are encountered with diabetes complications. Therefore, a treatment option that leads to modulate the immune system and mitigate the procedure of insulitis could be a hopeful clinical choice. Mesenchymal Stem Cells (MSC) have been shown to have immunomodulatory and...